Levetiracetam Fairmed Healthcare (Levetiracetam)

Levetiracetam binds to the synaptic vesicle protein SV2A, which modulates neurotransmitter release. This reduces neuronal hyper‑excitability and helps prevent the spread of epileptic activity across the brain.

The dosage of levetiracetam is individualized by the prescribing clinician based on the patient’s age, renal function, seizure type, and response to therapy. No fixed regimen is provided here.

Safety data for levetiracetam in pregnancy and lactation are limited. Clinicians should weigh potential benefits against risks and consider alternative therapies when appropriate. Breastfeeding decisions should be made in consultation with a healthcare professional.

To order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Levetiracetam offers a distinct mechanism by targeting SV2A, which differs from sodium‑channel blockers like carbamazepine. It has a relatively favorable drug‑interaction profile and is often chosen for patients who require a medication with minimal enzyme induction or inhibition.

Levetiracetam tablets should be stored at ambient temperature, preferably below 25 °C, in the original packaging to protect from moisture and light. Do not store in humid or excessively hot environments.

Levetiracetam is taken orally, usually with or without food, as a tablet or oral solution. The exact administration schedule is determined by the prescriber and may be once or twice daily depending on the therapeutic plan.

Serious risks include severe allergic reactions (e.g., rash, angioedema, anaphylaxis), significant mood changes such as depression or suicidal thoughts, and rare hematologic abnormalities like thrombocytopenia or neutropenia. Prompt medical attention is required if these occur.

Patients with known hypersensitivity to levetiracetam or any of its excipients should avoid the drug. Caution is also advised for individuals with severe renal impairment, uncontrolled psychiatric conditions, or those taking interacting medications without proper monitoring.